87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
New toolkit to support the collection of cancer-patient-reported outcome measures

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac
Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si
Overcoming glioblastoma resistance to chemotherapy

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &
Colorectal cancer risk factors important to consider for rescreening interval

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C
Researchers design novel immunotherapy for brain cancer

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm
Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo
Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in
Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x
Proof-of-concept study bioengineers therapeutics for improved cancer treatment

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut
Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si